Table 4. Experiment to experiment variation in cytokine/chemokine responses of PBMCs from same donor to HRV-infected Calu-3 cells.
| Cytokine/Chemokine | HRV 14 | HRV 16 | Uninfected | |||
| Exp 1 | Exp 2 | Exp 1 | Exp 2 | Exp 1 | Exp 2 | |
| FGF-Basic | 65 | 48 | 127 | 168 | 22 | 32 |
| IL-15 | 530 | 483 | 390 | 356 | 150 | 127 |
| IP-10 | 900 | 827 | 454 | 366 | 45 | 39 |
| IL-6 | 900 | 936 | 1288 | 1383 | 246 | 307 |
| MIP-1β | 209 | 298 | 17 | 25 | 13 | 22 |
| IFN-α | 1433 | 1366 | 146 | 207 | 134 | 196 |
| MCP-2 | 4644 | 4397 | 1439 | 1563 | 27 | 13 |
| IL-28A | 361 | 220 | 56 | 48 | 16 | 20 |
| ENA-78 | 12087 | 11932 | 16538 | 12498 | 10255 | 6632 |
Shown are the values of cytokine/chemokines (pg/ml) produced from the same source of PBMCs and data are for 48 hours after the time PBMCs were added to the Calu-3 cells.